Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan
· Delayed Price · Currency is JPY 1,591.00
+10.00 (0.63%)
Jul 10, 2025, 3:30 PM JST
Ono Pharmaceutical Revenue
In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B JPY, down -3.14%. Ono Pharmaceutical had revenue of 112.31B in the quarter ending March 31, 2025, a decrease of -0.41%.
Revenue
486.87B
Revenue Growth
-3.14%
P/S Ratio
1.53
Revenue / Employee
113.57M
Employees
4,287
Market Cap
742.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 486.87B | -15.80B | -3.14% |
| Mar 31, 2024 | 502.67B | 55.49B | 12.41% |
| Mar 31, 2023 | 447.19B | 85.83B | 23.75% |
| Mar 31, 2022 | 361.36B | 52.08B | 16.84% |
| Mar 31, 2021 | 309.28B | 16.86B | 5.77% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |
Ono Pharmaceutical News
- 17 days ago - Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea - Seeking Alpha
- 17 days ago - Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea - Benzinga
- 17 days ago - Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea - Business Wire
- 2 months ago - Ono Pharmaceutical Co., Ltd. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Ono Pharmaceutical reports FY results - Seeking Alpha
- 3 months ago - What's Going On With Cue Biopharma Shares Tuesday? - Benzinga
- 4 months ago - Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal - Benzinga
- 4 months ago - Ionis out licenses blood disorder therapy to Ono in a deal worth up to $940M - Seeking Alpha